These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 30393916

  • 1. Evaluation of fetal fibronectin for threatened preterm labour in reducing inappropriate interventions.
    Mahomed K, Anwar S, Geer JE, Ballard E, Okano S.
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):523-527. PubMed ID: 30393916
    [Abstract] [Full Text] [Related]

  • 2. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J, Mújica-Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill T, Kay T, Liversedge N, Parr M, Knight L, Hyde C, Shennan A, Hoyle M.
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [Abstract] [Full Text] [Related]

  • 3. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM, Liu E, Allenby K.
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY, Lee JY, Kim HM, Kim MJ, Cha HH, Seong WJ.
    BMC Pregnancy Childbirth; 2019 Jul 11; 19(1):241. PubMed ID: 31296172
    [Abstract] [Full Text] [Related]

  • 5. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY, Seto MTY, Lewis H, Cheung KW.
    BMC Pregnancy Childbirth; 2023 Apr 04; 23(1):225. PubMed ID: 37016314
    [Abstract] [Full Text] [Related]

  • 6. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, Melchor I, Burgos J.
    Ultrasound Obstet Gynecol; 2018 May 04; 51(5):644-649. PubMed ID: 28850753
    [Abstract] [Full Text] [Related]

  • 7. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN, van Asselt AD, Tomini F, Armstrong N, Allen A, Noake C, Khan K, Severens JL, Kleijnen J, Westwood ME.
    Health Technol Assess; 2013 Sep 04; 17(40):1-138. PubMed ID: 24060096
    [Abstract] [Full Text] [Related]

  • 8. Can fetal fibronectin testing improve the management of preterm labour?
    Owen P, Scott A.
    Clin Exp Obstet Gynecol; 1997 Sep 04; 24(1):19-22. PubMed ID: 9107450
    [Abstract] [Full Text] [Related]

  • 9. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM, Fox NS, Chasen ST.
    J Perinat Med; 2008 Sep 04; 36(3):202-5. PubMed ID: 18576928
    [Abstract] [Full Text] [Related]

  • 10. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I, Wallwiener D, Schmidt S.
    J Perinat Med; 2005 Sep 04; 33(5):383-91. PubMed ID: 16238532
    [Abstract] [Full Text] [Related]

  • 11. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation.
    Parker J, Bell R, Brennecke S.
    Aust N Z J Obstet Gynaecol; 1995 Aug 04; 35(3):257-61. PubMed ID: 8546638
    [Abstract] [Full Text] [Related]

  • 12. Compliance with Fetal Fibronectin Testing at a Canadian Tertiary Care Perinatal Centre.
    Black B, LeBlanc J, Dodds L, Armson BA, Nash CM.
    J Obstet Gynaecol Can; 2021 Feb 04; 43(2):191-196. PubMed ID: 32988804
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of the quantitative fetal fibronectin levels for the management of women presenting with threatened preterm labour - A revised cut off level: A retrospective cohort study.
    Mahomed K, Ibiebele I, Fraser C, Brown C.
    Eur J Obstet Gynecol Reprod Biol X; 2019 Oct 04; 4():100079. PubMed ID: 31508583
    [Abstract] [Full Text] [Related]

  • 14. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E, Roos C, Stone P, Hayward L, Mol BW, McCowan L.
    Aust N Z J Obstet Gynaecol; 2014 Jun 04; 54(3):231-6. PubMed ID: 24506318
    [Abstract] [Full Text] [Related]

  • 15. The diagnostic value of fetal fibronectin testing in clinical practice.
    Cornelissen LGH, van Oostrum NHM, van der Woude DAA, Rolf C, Porath MM, Oei SG, van Laar JOEH.
    J Obstet Gynaecol Res; 2020 Mar 04; 46(3):405-412. PubMed ID: 31955485
    [Abstract] [Full Text] [Related]

  • 16. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
    Roos C, Vis JY, Scheepers HC, Bloemenkamp KW, Duvekot HJ, van Eyck J, de Groot C, Kok JH, Opmeer BC, Oudijk MA, Papatsonis DN, Porath MM, Sollie K, Spaanderman ME, Lotgering FK, van der Post JA, Mol BW.
    J Matern Fetal Neonatal Med; 2016 Mar 04; 29(10):1556-61. PubMed ID: 26103778
    [Abstract] [Full Text] [Related]

  • 17. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
    Hermans FJR, Bruijn MMC, Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HCJ, Bloemenkamp KWM, Bax CJ, Cornette JMJ, Nij Bijvanck BWA, Franssen MTM, Vandenbussche FPHA, Kok M, Grobman WA, Van Der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ, Schuit E, Van Baaren GJ.
    Acta Obstet Gynecol Scand; 2015 Jul 04; 94(7):715-721. PubMed ID: 25845495
    [Abstract] [Full Text] [Related]

  • 18. The review of results of foetal fibronectin at the Royal Cornwall Hospital Treliske.
    Awe A, Watkins K.
    J Obstet Gynaecol; 2019 Apr 04; 39(3):319-322. PubMed ID: 30417723
    [Abstract] [Full Text] [Related]

  • 19. Clinical Application of Quantitative Foetal Fibronectin for the Prediction of Preterm Birth in Symptomatic Women.
    Radford SK, Da Silva Costa F, Araujo Júnior E, Sheehan PM.
    Gynecol Obstet Invest; 2018 Apr 04; 83(3):285-289. PubMed ID: 29183020
    [Abstract] [Full Text] [Related]

  • 20. Pilot study into the efficacy of foetal fibronectin testing in minimising hospital admissions in women presenting with symptoms of preterm labour: a randomised controlled trial of obstetric and neonatal outcomes.
    Dutta D, Norman JE.
    Arch Gynecol Obstet; 2011 Sep 04; 284(3):559-65. PubMed ID: 20957379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.